title: Different H-2 subregions influence immunization against retrovirus and immunosuppression.
abstract: Friend murine leukaemia virus complex (FV) causes an immunosuppressive retrovirus-induced disease. In certain mouse strains, FV shows striking similarities to human immunodeficiency virus (HIV) infection in man in that infected mice have severe T-cell immunosuppression but also develop virus-neutralizing antibodies incapable of eliminating infected cells. Previously we noted the influence of mouse major histocompatibility complex (H-2) genes on both FV-induced immunosuppression and on ability to protect mice against FV by immunizing with a vaccinia-Friend murine leukaemia helper virus (F-MuLV) envelope (env) recombinant virus. Here we show that different subregions of H-2 are involved in susceptibility to virus-induced immunosuppression (H-2D subregion) and protective immunization with a recombinant vaccinia virus (H-2K or I-A subregions). Thus, susceptibility to virus-induced immunosuppression does not preclude protection by vaccinia-Friend immunization. The mechanism of protection seems to involve priming of immune T cells, and not initial induction of neutralizing antibodies or cytotoxic T lymphocytes (CTL) (ref.2). Subsequent virus challenge generates a secondary response, resulting in appearance of IgG antibodies and CTL. In human HIV infection there could also be host genetic influences on elements of disease pathogenesis, such as immunosuppression, and on the success of T-cell priming by potential protective vaccines.
authors.affiliation: Laboratory of Persistent Viral Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana 59840.
authors.forename: R P
authors.initials: RP
authors.lastname: Morrison
authors.forename: P L
authors.initials: PL
authors.lastname: Earl
authors.forename: J
authors.initials: J
authors.lastname: Nishio
authors.forename: D L
authors.initials: DL
authors.lastname: Lodmell
authors.forename: B
authors.initials: B
authors.lastname: Moss
authors.forename: B
authors.initials: B
authors.lastname: Chesebro
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D005622:Friend murine leukemia virus / Q000276:immunology*; D005805:Genes, MHC Class I; D005802:Genes, MHC Class II; D006183:H-2 Antigens / Q000235:genetics*; D007108:Immune Tolerance; D007114:Immunization; D007942:Leukemia, Experimental / Q000276:immunology; D051379:Mice; D009500:Neutralization Tests; D018139:Simplexvirus / Q000276:immunology; D014614:Vaccines, Synthetic; D014616:Vaccinia virus / Q000276:immunology; D014759:Viral Envelope Proteins / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D006183:H-2 Antigens; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins